GLP-1 receptor agonist toxicity

Revision as of 20:05, 31 January 2024 by Rossdonaldson1 (talk | contribs)

Background

  • GLP-1 receptor agonists (e.g., semaglutide) are injectable medication used for diabetes management and weight loss
  • Poison control centers have reported increasing inquiries related to possible overdoses

Clinical Features

Differential Diagnosis

Evaluation

Workup

Diagnosis

Management

Disposition

See Also

External Links

References